We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we'll assume that you are happy to receive all cookies on the medicines.ie website. Find out more

GlaxoSmithKline (Ireland) Ltd

12 Riverwalk, Citywest Business Campus, Dublin 24, Ireland
Telephone: +353 1 495 5000
Fax: +353 1 4955225
Medical Information Direct Line: 1 800 244 255
Medical Information Facsimile: +353 1 495 5225
Patient Information Leaflet last updated on medicines.ie: 13/07/2017
PIL Bexsero Meningococcal Group B vaccine suspension for injection in pre-filled syringe

When a pharmaceutical company changes an SPC or PIL, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.

Updated on 13/07/2017 and displayed until Current
Reasons for adding or updating:
  • Change to section 4 - possible side effects
Updated on 10/10/2016 and displayed until 13/07/2017
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to drug interactions
  • Change to further information section
  • Change to date of revision
Updated on 09/03/2016 and displayed until 10/10/2016
Reasons for adding or updating:
  • Change to date of revision
  • Improved electronic presentation
Updated on 07/10/2015 and displayed until 09/03/2016
Reasons for adding or updating:
  • Change of manufacturer
  • Change to date of revision
  • Change to marketing authorisation holder
  • Change to MA holder contact details
Updated on 23/09/2015 and displayed until 07/10/2015
Reasons for adding or updating:
  • Change to side-effects
Updated on 30/01/2015 and displayed until 23/09/2015
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 26/09/2014 and displayed until 30/01/2015
Reasons for adding or updating:
  • Change to date of revision
  • Change to dosage and administration
Updated on 02/12/2013 and displayed until 26/09/2014
Reasons for adding or updating:
  • New PIL for new product

Document Links

 
  View all medicines
from this company
View Document
Bookmark and Share